PATENT CLAIM ANALYSIS

Application Number: 15866429
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["544", "234000"]

Abstract:
The invention provides novel compounds having the general formula: wherein R 1  to R 6  are as described herein, compositions including the compounds and methods of using the compounds.

Claim (Index 14):
The method of inhibiting HBsAg production or secretionin a cell comprising treating the cell with a therapeutically effective amount of a compound according to  claim 1 .

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.18519
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15674810', '14926393', '15144996', '15639966', '14610454']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7726604064792908
- 35 USC 102 Novelty (BERT): 0.5524402066466086
- Combined Prediction Score: 0.7506383864960225
- Mean Citation Score: 386.514236
- Max Citation Score: 415.42966
- Similarity Product: 351.2914841584039

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test